Issue #72

A useful tool or a hypochondriac's nightmare?

October 12, 2023

October 12, 2023 | Issue #72

Hey there! Have you gotten a preventative MRI scan? Or does the thought of it stress you out too much?

In this week's newsletter:😴 MRI Scans to Live Longer? đŸ’° VitaDAO Launches Matrix Biosciences🌐 Cosmo Goes Biohacking   

Preventative MRI Scans for Longevity: A Useful Tool or a Hypochondriac’s Nightmare?

Would you pay for a preventative MRI scan that might allow you to live 5-10 years longer? What if there was a chance that instead of helping you live longer, it actually harmed you?Would you still get a preventative MRI scan?Although you might live 5-10 years longer, due to discovering an internal health threat to your body, there are a number of negatives to consider when getting a preventative MRI scan.Some downsides include experiencing increased anxiety, follow-up with painstaking medical screenings, ineffective treatments for non-life-threatening health issues, time wasted, and large expenses. This is the crux of the personal and ethical challenge we’re facing with the rising popularity of preventative full-body magnetic resonance imaging (MRI) scans and elective preventative screenings in general. As preventive healthcare continues to rise, this debate will likely not go anywhere, especially as additional technology in the preventive healthcare space will continue to be developed. Additionally, major influencers have raised the public’s awareness about MRI scans for proactive healthcare. For example, Kim Kardshian created a #NotAnAd post on Instagram about her experience with Prenuvo, a full-body MRI cancer and disease screening service.  Despite the trending popularity and potential downsides of MRI scans, there are clearly enormous benefits. In this article we aim to educate you on the ins and outs of full-body MRI scans, as it pertains to longevity, so you can decide if this is right for you...

Are you joining us in Miami?

Confirmed speakers for Wonderland Miami include:

  • Cody Shirk, Founder/CEO, Spannr

  • Stephanie Dainow, Executive Director, Lifespan.io

  • Aubrey de Grey, Ph.D., President and CSO, LEV Foundation

  • Dr. Matthias Breugelmans, CEO at Elastrin Therapeutics Inc.

  • Phil Newman, Editor in Chief, Longevity.Technology

  • Dr. Halland Chen, The Longevity Doctor

  • J. Scotch McClure, CEO & Chairman Maxwell Biosciences, Inc.

  • Bryan Johnson, Founder/CEO Blueprint, Kernel & OS Fund

Register today using this link to get 20% off your ticket, or use "SPANNR20" at checkout. 

  • Regeneron is hiring for hundreds of positions VIEW HERE.

  • Browse thousands of jobs in the longevity industry, updated daily, in Spannr's new Jobs database HERE. 

  • VitaDAO, the global online community driving early-stage longevity research through innovative funding collaborations announced the launch of its very first biotech company, Matrix Biosciences. The community decision to launch Matrix Biosciences marks a significant step forward for VitaDAO as it advances its early portfolio assets toward its next development milestones. The first tranche of $300,000 from VitaDAO will be followed by further funding through IP-NFT fractionalization in early 2024.

  • Explore Spannr's Longevity Investor database HERE.

  • Ready to cold plunge? We dive into the science to see if it's worth it (NPR)

  • What is biohacking? And can it really lengthen our life span? (Cosmopolitan)

  • Investors Fuel Fountain of Youth Research with Longevity Company Funding (BioSpace)

  • More Americans Are Living to 100. Get Ready for the Super-Aging Era (Time)

  • Chris Hemsworth shares 4 things he does for longevity and to protect his brain health after discovering his Alzheimer's risk (Insider)

  • Is the Eye the Window to Alzheimer’s? (WSJ)

  • Renters are more stressed than the unemployed—and they’re aging faster because of it, new research finds (Fortune)

  • Why you should never skip cardio workouts (even if you find them boring) (GQ)

  • The Secret to Living to 100? It’s Not Good Habits (WSJ)

Performance:

Latest Price: $85.437d-Return: 1.7%Market Cap: $8.7b

Big Movers:Longeveron (LGNV): -33.86%Celularity (CELU): 21.74%Vaxxinity (VAXX): -15.79%

ABOUT SPANNR

We are dedicated to helping people understand the biggest business and health story of all time: the unprecedented transformation of society that will result from extending human healthspan and lifespan.

If you have any questions about Spannr or want to get to know us better, 

 â€“ we'd love to hear from you. We appreciate your interest in what we are creating.